BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27995954)

  • 21. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
    Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
    BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D.
    Ma Y; Gong J; Liu Y; Guo W; Jin B; Wang X; Chen L
    Life Sci; 2016 Apr; 151():174-181. PubMed ID: 26968781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.
    Park KS; Park JH; Song YW
    Tissue Antigens; 2008 Oct; 72(4):342-6. PubMed ID: 18700876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
    Lee JC; Lee KM; Kim DW; Heo DS
    J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.
    Garcia-Chagollan M; Jave-Suarez LF; Haramati J; Sanchez-Hernandez PE; Aguilar-Lemarroy A; Bueno-Topete MR; Pereira-Suarez AL; Fafutis-Morris M; Cid-Arregui A; del Toro-Arreola S
    J Biomed Sci; 2013 Aug; 20(1):60. PubMed ID: 23947399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression.
    Xie J; Liu M; Li Y; Nie Y; Mi Q; Zhao S
    Cell Mol Immunol; 2014 Sep; 11(5):495-502. PubMed ID: 24813230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.
    Karimi MA; Aguilar O; Zou B; Bachmann MH; Carlyle JR; Baldwin CL; Kambayashi T
    J Immunol; 2014 Sep; 193(6):2764-2771. PubMed ID: 25092887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
    von Lilienfeld-Toal M; Frank S; Leyendecker C; Feyler S; Jarmin S; Morgan R; Glasmacher A; Märten A; Schmidt-Wolf IG; Brossart P; Cook G
    Cancer Immunol Immunother; 2010 Jun; 59(6):829-39. PubMed ID: 20024547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.
    Crane CA; Han SJ; Barry JJ; Ahn BJ; Lanier LL; Parsa AT
    Neuro Oncol; 2010 Jan; 12(1):7-13. PubMed ID: 20150362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
    Okita R; Wolf D; Yasuda K; Maeda A; Yukawa T; Saisho S; Shimizu K; Yamaguchi Y; Oka M; Nakayama E; Lundqvist A; Kiessling R; Seliger B; Nakata M
    PLoS One; 2015; 10(10):e0139809. PubMed ID: 26439264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma.
    Wang T; Sun F; Wang Y; Jiang J; Pan M; Yuan M; Zhang H; Du X; Hezam K; Song K; Wang M; Zhang J
    J Immunother; 2018 Apr; 41(3):109-117. PubMed ID: 29528990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
    Huergo-Zapico L; Acebes-Huerta A; Gonzalez-Rodriguez AP; Contesti J; Gonzalez-García E; Payer AR; Villa-Alvarez M; Fernández-Guizán A; López-Soto A; Gonzalez S
    PLoS One; 2014; 9(10):e108326. PubMed ID: 25286418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human tumor-derived exosomes down-modulate NKG2D expression.
    Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
    J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
    Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
    PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms.
    Du Y; Liu X; Guo SW
    Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells.
    Nagai Y; Tanaka Y; Kuroishi T; Sato R; Endo Y; Sugawara S
    Immunology; 2012 May; 136(1):103-14. PubMed ID: 22304689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese.
    Furue H; Matsuo K; Kumimoto H; Hiraki A; Suzuki T; Yatabe Y; Komori K; Kanemitsu Y; Hirai T; Kato T; Ueda M; Ishizaki K; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):316-20. PubMed ID: 18174257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B; Missé D; Richon C; Vergnon I; Kubin M; Soria JC; Moretta A; Chouaib S; Mami-Chouaib F
    Int Immunol; 2008 Jul; 20(7):801-10. PubMed ID: 18441340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.